FR1601438A - - Google Patents

Info

Publication number
FR1601438A
FR1601438A FR170197A FR1601438DA FR1601438A FR 1601438 A FR1601438 A FR 1601438A FR 170197 A FR170197 A FR 170197A FR 1601438D A FR1601438D A FR 1601438DA FR 1601438 A FR1601438 A FR 1601438A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR170197A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1601438A publication Critical patent/FR1601438A/fr
Expired legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F27D11/08—Heating by electric discharge, e.g. arc discharge
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21C—PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C5/00—Manufacture of carbon-steel, e.g. plain mild steel, medium carbon steel or cast steel or stainless steel
    • C21C5/52—Manufacture of steel in electric furnaces
    • C21C5/5252—Manufacture of steel in electric furnaces in an electrically heated multi-chamber furnace, a combination of electric furnaces or an electric furnace arranged for associated working with a non electric furnace
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D3/00—Charging; Discharging; Manipulation of charge
    • F27D3/18—Charging particulate material using a fluid carrier

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Vertical, Hearth, Or Arc Furnaces (AREA)
  • Furnace Details (AREA)
  • Discharge Heating (AREA)
FR170197A 1968-10-17 1968-10-17 Expired FR1601438A (index.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR170197 1968-10-17

Publications (1)

Publication Number Publication Date
FR1601438A true FR1601438A (index.php) 1970-08-24

Family

ID=8655735

Family Applications (1)

Application Number Title Priority Date Filing Date
FR170197A Expired FR1601438A (index.php) 1968-10-17 1968-10-17

Country Status (10)

Country Link
US (1) US3610795A (index.php)
JP (1) JPS4829422B1 (index.php)
BE (1) BE739974A (index.php)
BR (1) BR6913348D0 (index.php)
DE (1) DE1952407B2 (index.php)
ES (1) ES372628A1 (index.php)
FR (1) FR1601438A (index.php)
GB (1) GB1252310A (index.php)
LU (1) LU59646A1 (index.php)
SE (1) SE364311B (index.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2220584A1 (index.php) * 1973-03-05 1974-10-04 Siderurgie Fse Inst Rech

Families Citing this family (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891427A (en) * 1972-10-12 1975-06-24 Lectromelt Corp Method for melting prereduced ore and scrap
SE378735B (index.php) * 1972-11-17 1975-09-08 Asea Ab
US3939297A (en) * 1973-12-07 1976-02-17 Chase Brass & Copper Co., Incorporated Stoker feed system
SE7503782L (sv) * 1975-04-02 1976-10-03 Asea Ab Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
DE2632707C3 (de) * 1976-07-21 1983-04-07 Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
US4133967A (en) * 1977-06-24 1979-01-09 The United States Of America As Represented By The Secretary Of The Interior Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
US4447906A (en) * 1981-02-02 1984-05-08 Lectromelt Corporation Arc furnace for producing aluminum
SE8303372L (sv) * 1983-06-14 1984-12-15 Asea Ab Ugnsanordning for smeltning av metaller eller metallegeringar
AT384669B (de) * 1986-03-17 1987-12-28 Voest Alpine Ag Anlage zur herstellung von stahl aus schrott
CA1311787C (en) * 1986-06-24 1992-12-22 Masahisa Tate Method of bottom blowing operation of a steel making electric furnace
FR2705767B1 (fr) * 1993-05-27 1995-07-21 Lorraine Laminage Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
DE4339226A1 (de) * 1993-11-15 1995-05-18 Mannesmann Ag Verfahren und Vorrichtung zur Wertstoffgewinnung
LU88517A7 (fr) * 1993-12-15 1996-02-01 Wurth Paul Sa Dispositif de chargement d'un four électrique
AT404841B (de) * 1995-04-10 1999-03-25 Voest Alpine Ind Anlagen Anlage und verfahren zum herstellen von eisenschmelzen
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
AU5273700A (en) * 1999-05-18 2000-12-05 Danieli Technology, Inc. Electric arc furnace for continuous charging
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
AU2001276957A1 (en) * 2000-07-17 2002-01-30 Advanced Research And Technology Institute Method of diagnosing pulmonary hypertension
EP2336166A1 (en) 2000-10-12 2011-06-22 University Of Rochester Compositions that inhibit proliferation of cancer cells
US20040245317A1 (en) * 2001-04-06 2004-12-09 Vladimir Larionov Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
KR20040045041A (ko) * 2001-10-01 2004-05-31 반더빌트유니버시티 구조적 심장 질환에서의 심근 기능장애를 치료하기 위한칼모듈린 키나제 ⅱ 억제제의 용도
AU2002332027A1 (en) * 2001-10-04 2003-04-14 The Government Of The United States Of America, As Tandem repeat markers
DE60332756D1 (de) 2002-02-06 2010-07-08 Vicor Technologies Inc Anti-infarkt-moleküle
US7666411B2 (en) 2002-06-14 2010-02-23 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating and preventing colitis involving IL-13 and NK-T cells
WO2004013160A2 (en) 2002-08-05 2004-02-12 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
CA2505601C (en) 2002-11-15 2014-10-28 Musc Foundation For Research Development Complement receptor 2 targeted complement modulators
ATE542423T1 (de) 2002-11-21 2012-02-15 Univ Utah Res Found Purinerge geruchsmodulation
CA2553745A1 (en) 2004-01-21 2005-08-04 University Of Utah Research Foundation Mutant sodium channel nav1.7 and methods related thereto
AU2005220874B2 (en) 2004-03-04 2010-12-23 Vanderbilt University Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
WO2006016904A2 (en) * 2004-04-14 2006-02-16 Uab Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
US20050244335A1 (en) * 2004-05-03 2005-11-03 Rinehart John J Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
CA2566703A1 (en) 2004-05-11 2005-11-24 Vishwa Deep Dixit Methods of inhibiting proinflammatory cytokine expression using ghrelin
US8039588B2 (en) 2004-05-21 2011-10-18 The Uab Research Foundation Variable lymphocyte receptors
WO2006055875A2 (en) * 2004-11-18 2006-05-26 University Of Rochester Methods and compositions related to esculentoside a
DK2377546T3 (en) 2004-12-21 2017-02-13 Musc Found For Res Dev Compositions and Methods to Promote Wound Healing and Tissue Regeneration
WO2006113614A2 (en) 2005-04-15 2006-10-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Service National Institutes Of Health Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells
EP1931700B1 (en) 2005-05-19 2013-07-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
US8859585B2 (en) * 2005-05-25 2014-10-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Scopolamine for the treatment of depression and anxiety
ES2626018T3 (es) 2005-06-07 2017-07-21 Dsm Nutritional Products Ag Microorganismos eucariotas para la producción de lípidos y antioxidantes
EP2395076A1 (en) 2005-10-14 2011-12-14 MUSC Foundation For Research Development Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
US8080534B2 (en) 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
EP2653542B1 (en) 2005-12-29 2016-06-29 The Regents of The University of California Methods and compositions related to mutant kunitz domain I of TFPI-2
WO2007081792A2 (en) 2006-01-05 2007-07-19 University Of Utah Research Foundation Methods and compositions related to improving properties of pharmacological agents targeting nervous system
EP2510943B1 (en) 2006-02-06 2016-04-20 The Burnham Institute for Medical Research Methods and compositions related to targeting tumors and wounds
US8470965B2 (en) * 2006-03-01 2013-06-25 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
AU2007223427A1 (en) * 2006-03-01 2007-09-13 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
WO2007101274A2 (en) 2006-03-02 2007-09-07 The Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
EP2043642B1 (en) 2006-07-10 2015-03-25 Synapsin Pharmaceuticals, Inc. Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
EP2049564B1 (en) 2006-08-02 2017-05-17 The UAB Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
AU2007297535C1 (en) 2006-09-21 2017-11-23 University Of Florida Research Foundation, Inc. Compositions and methods related to protein displacement therapy for myotonic distrophy
WO2008136852A2 (en) 2006-11-01 2008-11-13 University Of Rochester Methods and compositions related to the structure and function of apobec3g
WO2008073441A2 (en) 2006-12-11 2008-06-19 University Of Utah Research Foundation Compositions and methods for treating pathologic angiogenesis and vascular permeability
US20120030779A1 (en) 2007-01-18 2012-02-02 University Of Utah Research Foundtion Compositions and methods for detecting, treating, or preventing reductive stress
EP2596799B1 (en) 2007-02-08 2016-11-23 University of Utah Research Foundation Methods and compositions related to inhibition of viral entry
EP2139319A4 (en) 2007-03-22 2011-02-23 Univ Yale METHOD AND COMPOSITIONS FOR RIBOSWITCHES CONTROLLING THE ALTERNATIVE SPLICE
US8119693B2 (en) 2007-05-08 2012-02-21 Sanford-Burnham Medical Research Institute Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
EP2155894A4 (en) 2007-05-09 2010-08-18 Burnham Inst Medical Research HOST PROTEINAS AS A TARGET FOR A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL DISEASES
US8329195B2 (en) 2007-05-23 2012-12-11 The Uab Research Foundation Detoxified pneumococcal neuraminidase and uses thereof
SG174103A1 (en) 2007-05-29 2011-09-29 Univ Yale Riboswitches and methods and compositions for use of and with riboswitches
DK2166845T3 (en) 2007-06-21 2016-02-01 Musc Found For Res Dev ALFA-connexin C-terminal (ACT) peptides FOR THE TREATMENT OF AGE-related macular degeneration
TW200916113A (en) 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2009021163A2 (en) * 2007-08-08 2009-02-12 University Of Rochester Enhancing gene transfer
EP2190466A4 (en) * 2007-08-10 2011-12-21 Burnham Inst Medical Research Tissue-specific alkaline phosphatase (TNAP) activators and their use
EP2268664B1 (en) 2007-12-03 2017-05-24 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Doc1 compositions and methods for treating cancer
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
EP2853897A1 (en) 2008-05-08 2015-04-01 University Of Utah Research Foundation Sensory receptors for chronic fatigue and pain and uses thereof
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
WO2010019963A2 (en) * 2008-08-15 2010-02-18 Georgetown University Na channels, disease, and related assays and compositions
WO2010065617A1 (en) 2008-12-02 2010-06-10 University Of Utah Research Foundation Pde1 as a target therapeutic in heart disease
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
US20120107331A1 (en) 2009-05-15 2012-05-03 Yale University Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
WO2011020107A2 (en) 2009-08-14 2011-02-17 Georgetown University Compositions and methods for detection and treatment of breast cancer
US20120149663A1 (en) 2009-08-18 2012-06-14 Georgetown University Boronic acid compositions and methods related to cancer
US20110060000A1 (en) 2009-09-10 2011-03-10 Maurizio Grimaldi Acridine analogs in the treatment of gliomas
SG182365A1 (en) 2010-01-12 2012-08-30 Univ Yale Structured rna motifs and compounds and methods for their use
WO2011112670A2 (en) 2010-03-09 2011-09-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
JP2013525285A (ja) 2010-04-08 2013-06-20 サンフォード−バーナム メディカル リサーチ インスティテュート 化合物の送達を増強するための方法および組成物
US20130143955A1 (en) 2010-08-09 2013-06-06 Yale University Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
SG193500A1 (en) 2011-03-15 2013-10-30 Univ Utah Res Found Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
JP6205345B2 (ja) 2011-03-28 2017-09-27 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション ウイルス侵入の阻害に関する方法および組成物
WO2013036636A1 (en) 2011-09-06 2013-03-14 Dana-Farber Cancer Institute, Inc. Compositions and methods of treating cancer
EP2870238A4 (en) 2012-07-05 2016-03-09 Ohio State Innovation Foundation COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES
WO2014141111A1 (en) 2013-03-14 2014-09-18 Pluristem Ltd. Methods for prevention and treatment of graft-versus-host disease
WO2014201118A2 (en) 2013-06-11 2014-12-18 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
RS59925B1 (sr) 2013-07-05 2020-03-31 H Lee Moffitt Cancer Center And Research Institute Inc Rastvorljivi cd33 za lečenje mijelodisplastičnih sindroma (mds)
US9884895B2 (en) 2014-03-20 2018-02-06 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
WO2016049380A1 (en) 2014-09-24 2016-03-31 University Of Utah Research Foundation Ebolavirus pre-hairpin intermediate mimics and methods of use
JP2018504141A (ja) 2015-01-20 2018-02-15 アドキュア バイオテクノロジーズ、 エルエルシー 非標的化アデノウイルス変異体および関連する方法
HK1248554A1 (zh) 2015-02-20 2018-10-19 Board Of Regents, The University Of Texas System 作为疫苗和载体的减毒衣原体的方法和组合物
WO2017040350A1 (en) 2015-08-28 2017-03-09 Navigen, Inc Compositions and methods related to inhibition of respiratory syncytial virus entry
WO2017120549A1 (en) 2016-01-07 2017-07-13 Navigen, Inc. D-peptide inhibitors of hiv entry and methods of use
KR102477922B1 (ko) 2016-03-16 2022-12-14 아베오미 코포레이션 Il-25에 대한 중화 모노클로날 항체 및 그의 용도
US10751340B2 (en) 2016-06-06 2020-08-25 University Of Central Florida Research Foundation, Inc. Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
BR112019001737A2 (pt) 2016-07-29 2019-05-07 Ohio State Innovation Foundation expressão de pten-long com vírus oncolíticos
CN118453850A (zh) 2016-10-05 2024-08-09 弗罗里达中央大学研究基金会 涉及nk细胞和抗pdl1癌症治疗的方法和组合物
KR102811217B1 (ko) 2017-02-28 2025-05-22 유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 Nk 세포의 골수 호밍을 개선시키는 pm21 입자
WO2018176027A1 (en) 2017-03-24 2018-09-27 Ohio State Innovation Foundation Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
AU2018243920B2 (en) 2017-03-28 2024-12-12 Mayo Foundation For Medical Education And Research Human PD1 peptide vaccines and uses thereof
EP3615052B1 (en) 2017-04-27 2023-01-25 The University of Hong Kong Use of hcn inhibitors for treatment of cancer
KR20240132124A (ko) 2017-05-25 2024-09-02 유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 천연 살해 세포에 의해 사멸하는 종양 세포를 감작시키기 위한 신규한 종양용해 바이러스
WO2019067403A2 (en) 2017-09-26 2019-04-04 Sanford Burnham Prebys Medical Discovery Institute COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
US12053523B2 (en) 2017-12-13 2024-08-06 North Carolina State University Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
WO2019195819A1 (en) 2018-04-06 2019-10-10 North Carolina State University Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
US11717551B2 (en) 2018-05-07 2023-08-08 Georgia State University Research Foundation, Inc. Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
KR102846479B1 (ko) 2018-05-16 2025-08-18 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 Cas9 리보핵단백질을 사용하는 녹아웃 일차 및 확장된 인간 nk 세포의 생성
KR20210042268A (ko) 2018-05-30 2021-04-19 다이렉트 바이오로직스 엘엘씨 간엽 줄기 세포(msc) 제제를 포함하는 성장 인자 및 세포외 소포 냉동 또는 분말화 첨가제 및 사용 방법
US20210260187A1 (en) 2018-06-29 2021-08-26 North Carolina State University In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
US11331269B2 (en) 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
US20210317479A1 (en) 2018-09-06 2021-10-14 The Broad Institute, Inc. Nucleic acid assemblies for use in targeted delivery
WO2020072764A1 (en) 2018-10-03 2020-04-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
US20210388389A1 (en) 2018-10-30 2021-12-16 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
EP3873505A4 (en) 2018-11-02 2022-08-10 The Johns Hopkins University ADENOVIRAL CHIMERA TDP-43 PROTEINS
US20220136064A1 (en) 2019-02-09 2022-05-05 King Abdullah University Of Science And Technology Compositions and methods for cancer diagnosis and prognosis
BR112021025795A2 (pt) 2019-06-21 2022-02-01 H Lee Moffitt Cancer Center And Res Institute Inc A Florida Non Profit Corporation Terapia de combinação com bloqueio da semaforina-4d (sema4d) e terapia com dc1
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
BR112022008215A2 (pt) 2019-10-31 2022-07-12 Res Inst Nationwide Childrens Hospital Geração de células nk humanas primárias e expandidas knock-out de cd38
JP2023521837A (ja) 2020-04-14 2023-05-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 大きな配列の汎コロナウイルスワクチン組成物
US11225508B1 (en) 2020-09-23 2022-01-18 The University Of North Carolina At Chapel Hill Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
WO2022115474A1 (en) 2020-11-27 2022-06-02 General Nanotherapeutics Llc Methods and composition for treatment of immune-mediated diseases
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
KR102436232B1 (ko) * 2022-01-17 2022-08-25 주식회사 세명하이트 원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
US20250228940A1 (en) 2022-03-11 2025-07-17 Yale University Compositions and methods for efficient and stable genetic modification of eukaryotic cells
WO2023220644A1 (en) 2022-05-10 2023-11-16 Yale University Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
KR102751454B1 (ko) * 2022-06-03 2025-01-10 현대제철 주식회사 전기로
KR102736561B1 (ko) * 2022-06-03 2024-12-02 현대제철 주식회사 전기로
KR102777625B1 (ko) * 2022-07-29 2025-03-11 현대제철 주식회사 전기로
KR102829902B1 (ko) * 2022-07-29 2025-07-04 현대제철 주식회사 전기로
KR102793154B1 (ko) * 2022-08-26 2025-04-07 현대제철 주식회사 전기로
KR102752443B1 (ko) * 2022-08-26 2025-01-09 현대제철 주식회사 전기로
WO2024064824A2 (en) 2022-09-21 2024-03-28 Yale University Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
WO2024102997A1 (en) 2022-11-11 2024-05-16 Peterson Jeff R Gout flare prevention methods using il-1β inhibitors
KR102799788B1 (ko) * 2022-11-29 2025-04-22 현대제철 주식회사 전기로용 저취교반장치 및 이를 포함하는 전기로
WO2024155821A1 (en) 2023-01-18 2024-07-25 Yale University Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
WO2024226829A2 (en) 2023-04-26 2024-10-31 Yale University Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
WO2024238656A1 (en) 2023-05-15 2024-11-21 Yale Univeristy Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
WO2025158400A1 (en) 2024-01-24 2025-07-31 Yale University Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
WO2025264861A1 (en) 2024-06-18 2025-12-26 Yale University Compositions of bi-functional alpha helical peptides and methods thereof for treating tdp-43 proteinopathies
WO2026006542A2 (en) 2024-06-26 2026-01-02 Yale University Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US848422A (en) * 1905-06-23 1907-03-26 Frank Wynne Method of maintaining or increasing the fluidity of molten or semimolten materials by means of electricity.
US1339428A (en) * 1916-03-24 1920-05-11 Ludlum Electric Furnace Corp Method of operating an electric furnace

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2220584A1 (index.php) * 1973-03-05 1974-10-04 Siderurgie Fse Inst Rech

Also Published As

Publication number Publication date
DE1952407A1 (de) 1970-08-20
SE364311B (index.php) 1974-02-18
ES372628A1 (es) 1971-11-01
BE739974A (index.php) 1970-03-16
BR6913348D0 (pt) 1973-01-02
JPS4829422B1 (index.php) 1973-09-10
US3610795A (en) 1971-10-05
LU59646A1 (index.php) 1970-01-12
GB1252310A (index.php) 1971-11-03
DE1952407B2 (de) 1971-03-11

Similar Documents

Publication Publication Date Title
FR1601438A (index.php)
AU5506869A (index.php)
AU5184069A (index.php)
AU6168869A (index.php)
AU6171569A (index.php)
AU4811568A (index.php)
AU4744468A (index.php)
BE709484A (index.php)
BE709320A (index.php)
BE728605A (index.php)
BE728449A (index.php)
BE727768A (index.php)
BE727653A (index.php)
BE727038A (index.php)
BE726876A (index.php)
BE726705A (index.php)
BE726306A (index.php)
BE721655A (index.php)
BE719619A (index.php)
BE709496A (index.php)
BE728699A (index.php)
BE709479A (index.php)
BE709446A (index.php)
BE709435A (index.php)
BE709415A (index.php)

Legal Events

Date Code Title Description
ST Notification of lapse